Experience briefs.
- Published in:
- 1997
- By:
- Publication type:
- Case Study
Works matching IS 1082801X AND DT 1997 AND VI 32 AND IP 5
Results: 12
1
2
Washington update.
- Published in:
- Formulary, 1997, v. 32, n. 5, p. 552
- By:
- Publication type:
- Article
3
Abstracts.
- Published in:
- Formulary, 1997, v. 32, n. 5, p. 548
- Publication type:
- Article
4
Meeting highlights.
- Published in:
- Formulary, 1997, v. 32, n. 5, p. 544
- Publication type:
- Article
5
How to calculate the cost effectiveness of a specialty clinic.
- Published in:
- Formulary, 1997, v. 32, n. 5, p. 527
- By:
- Publication type:
- Article
6
Benchmarking evaluation of 5-HT[sub 3]-receptor antagonist use in emetogenic chemotherapy.
- Published in:
- Formulary, 1997, v. 32, n. 5, p. 515
- By:
- Publication type:
- Article
7
Insights on outpatient formulary management in a vertically integrated health care system.
- Published in:
- 1997
- By:
- Publication type:
- Interview
8
Recommended management of the MS patient.
- Published in:
- Formulary, 1997, v. 32, n. 5, p. 488
- Publication type:
- Article
9
Multiple sclerosis: A pharmacotherapy update.
- Published in:
- Formulary, 1997, v. 32, n. 5, p. 472
- By:
- Publication type:
- Article
10
Focus on zileuton: The first FDA-approved agent of a new class of drugs--the 5-lipoxygenase inhibitors--for the management of asthma.
- Published in:
- Formulary, 1997, v. 32, n. 5, p. 455
- By:
- Publication type:
- Article
11
News and product notes.
- Published in:
- Formulary, 1997, v. 32, n. 5, p. 446
- Publication type:
- Article
12
News capsules.
- Published in:
- Formulary, 1997, v. 32, n. 5, p. 441
- Publication type:
- Article